Study of AKCEA-ANGPTL3-LRX (ISIS 703802) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)

NCT03455777 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study withdrawn due to lack of available patients meeting entry criteria

Conditions

Homozygous Familial Hypercholesterolemia

Interventions

DRUG: AKCEA-ANGPTL3-LRX

Sponsor

Akcea Therapeutics

Collaborators

[object Object]